Tracking symptoms by day-after-dose instead of as isolated events makes patterns easier to spot
These central effects translate into substantial weight loss - typically 5%-15% of body weight with current GLP-1 RAs - which directly ameliorates hepatic steatosis by reducing adipose tissue mass, reducing hepatic free fatty acid influx, and improving insulin sensitivity
However, the findings that the stable gastric pentadecapeptide BPC 157 might beneficially affect striated and smooth muscle and heart might suggest that it most perfectly matched [32,33,34] with the original Roberts and Szabos cytoprotective theory and concept [35,36,37,38,39,40,41,42]
For direct fat reduction, Tesamorelin (visceral fat reduction) and CJC/Ipamorelin (growth hormone stimulation for lean body composition) are more relevant than GHK-Cu